These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11923169)

  • 1. Statins as the new aspirin. Conclusions from the heart protection study were premature.
    Ravnskov U
    BMJ; 2002 Mar; 324(7340):789. PubMed ID: 11923169
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
    Collins R
    Am J Manag Care; 2002 Jan; Suppl():6. PubMed ID: 11833455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
    MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687
    [No Abstract]   [Full Text] [Related]  

  • 4. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids].
    Arnheim K
    MMW Fortschr Med; 2000 Jun; 142(24):18. PubMed ID: 10895577
    [No Abstract]   [Full Text] [Related]  

  • 7. Safe use of ezetimibe plus simvastatin in high-risk vascular patients (with chronic kidney disease and PAD).
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):227-8. PubMed ID: 21881698
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
    Lasocki A; Vote B; Fassett R; Zamir E
    Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term statin therapy appears safe.
    Harv Heart Lett; 1999 Aug; 9(12):6-7. PubMed ID: 10402353
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of simvastatin is not influenced by CYP2D6 polymorphism.
    Geisel J; Kivistö KT; Griese EU; Eichelbaum M
    Clin Pharmacol Ther; 2002 Nov; 72(5):595-6. PubMed ID: 12426523
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simvastatin after myocardial infarct. Losing no time].
    MMW Fortschr Med; 2001 Apr; 143(15):51. PubMed ID: 11349324
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe + simvastatin (Merck/Schering-Plough).
    Flores NA
    Curr Opin Investig Drugs; 2004 Sep; 5(9):984-92. PubMed ID: 15503655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
    Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypercholesterolemia in high risk patients. Targeting low goal values].
    MMW Fortschr Med; 2001 Apr; 143(15):50-1. PubMed ID: 11349323
    [No Abstract]   [Full Text] [Related]  

  • 16. [The other face of statins].
    Kaletha K; Chodorowski Z; Sein Anand J; Szydłowska M; Rybakowska I; Nagel-Starczynowska G
    Przegl Lek; 2002; 59(4-5):364-6. PubMed ID: 12184008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis in prostate cancer--caution in prescribing cyproterone acetate with statins.
    Ahamed E; Bissett D
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):528-9. PubMed ID: 15630845
    [No Abstract]   [Full Text] [Related]  

  • 19. Report of simultaneous acute pancreatitis and acute hepatitis in a patient taking ezetimibe/simvastatin.
    Van Woerkom RC; Adler DG
    J Clin Lipidol; 2010; 4(4):314-5. PubMed ID: 21122666
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment.
    Antonopoulos S; Mikros S; Kokkoris S; Protopsaltis J; Filioti K; Karamanolis D; Giannoulis G
    JOP; 2005 May; 6(3):264-8. PubMed ID: 15883478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.